NCT03353402 - Fecal Microbiota Transplantation (FMT) & Melanoma (cutaneous) (failed at least one line of PD-1 blockade)

What is being investigated in the randomized clinical trial NCT03353402?

An open label phase I treatment trial (Single Group Assignment) evaluating Fecal Microbiota Transplantation (FMT) in patients with Melanoma (cutaneous) (failed at least one line of PD-1 blockade). Primarily, safety, the comparison of the patients' gut bacterial composition before and after FMT, as well as in relation to their donors, will be conducted. The bacterial composition will be quantified using the operational taxonomic unit (OTU) in the stool.

What are the results of the randomized clinical trial NCT03353402?

No published results were found as of May 2026